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Notch signaling is required for multiple aspects of cardiovascular development, including arterial-venous differentiation, septation and
cushion formation. Despite recognition of the importance of the Notch pathway in normal cardiovascular development, the proximate
downstream effectors are not yet known. Likely candidate effectors are members of the hairy and enhancer of split related (hesr) family of bHLH
transcription factors. However, mutational analysis of individual hesr genes has so far failed to elucidate their role in all Notch-mediated
cardiovascular signaling events. An example of this is evident for mutants of gridlock, the zebrafish counterpart of mouse hesr2, which have
vascular defects, whereas mouse hesr2 mutants have only cardiac defects. One possible explanation for these differences could be functional
redundancy between hesr family members. Here, we report that mice lacking the hesr1 gene are viable and fertile, whereas knockout mouse of
both hesr1 and hesr2 is embryonic lethal at 11.5 days postcoitum (dpc) and recapitulates most of the known cardiovascular phenotypes of
disrupted Notch pathwaymutants including defects in arterial-venous specification, septation and cushion formation. Taken together, our results
demonstrate a requirement for hesr1 and hesr2 in mediating Notch signaling in the developing cardiac and vascular systems.
D 2004 Elsevier Inc. All rights reserved.
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The cardiovascular system is the first organ system to
form during embryogenesis and the cardiac and vascular
endothelia play essential roles in this process. During cardiac
development, the inner cardiac endothelium regulates the
maturation of the outer myocardium, which is required for
trabecular formation (Brutsaert et al., 1998). Coalescence of
trabeculations at the apex of the heart results in the formation
of a muscular ventricular septum that divides the primitive0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.10.025
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E-mail address: hkokubo@lab.nig.ac.jp (H. Kokubo).ventricle into the right and left ventricles early in develop-
ment (Ben-Shachar et al., 1985). Luminal endothelial cells in
the regions of both the atrioventricular (AV) cushion and
outflow tract undergo epithelial–mesenchymal transforma-
tion and participate in the formation of valves and
membranous septa (Runyan and Markwald, 1983). During
vascular development, after a primary vascular plexus has
formed, more vascular endothelial cells are generated, and
these form new capillaries by sprouting or splitting from
their vessel of origin in a process termed angiogenesis
(reviewed in Risau, 1997). Reciprocal interactions between
vascular endothelial cells, vascular mesenchymal cells and
the surrounding matrix are essential in this process.
Notch signaling is essential for cardiac and vascular
morphogenesis in mice. In the heart, endothelial cells,278 (2005) 301–309
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for a requirement of Notch signaling during cardiovascular
development came from studies of mice that contain a
processing-deficient allele of Notch1. These mice exhibit
heart anomalies, including a distended pericardium (Hup-
pert et al., 2000; Timmerman et al., 2004). Furthermore, a
transcriptional co-factor of Notch, RBPJk, expressed in
cardiac endothelial cells, has been shown to be essential for
epithelial to mesenchymal transformation (EMT) (Timmer-
man et al., 2004). Additionally, hypomorphic mutants of
Notch2, which is expressed in the myocardium, exhibit a
thinning of the myocardial wall (McCright et al., 2002).
Moreover, mice mutants for the Notch ligand, Jagged1,
which causes the autosomal dominant disorder Alagille
syndrome in humans (Li et al., 1997; Oda et al., 1997),
exhibit embryonic lethality and vascular defects (Xue et al.,
1999) and Jagged1 and hypomorphic Notch2 double
heterozygous mutants show further defects in heart, eye
and kidney development, which parallel the defects
observed in Alagille syndrome in humans (McCright et
al., 2002). Additional evidence supporting a role for notch
signaling in vascular development stems from the observa-
tions that Notch1, Notch3, Notch4, Delta4, Jagged1 and
Jagged2 are all expressed in arterial tissues (Krebs et al.,
2000; Villa et al., 2001) and mutations in these genes results
in vascular defects (Huppert et al., 2000; McCright et al.,
2002; Shutter et al., 2000; Xue et al., 1999).
The hesr family of bHLH transcription factors was
identified through its similarity to the hairy and enhance of
split (hes) family of genes, which are downstream targets of
Notch signaling in Drosophila. In both mouse and human,
there are three hesr genes, hesr1-3, (also known as hey, hrt,
chf, gridlock, ""or herp) that form a distinct subfamily of
bHLH-containing transcriptional repressors from the hes
genes. Previous studies of mouse knockouts for hesr2 have
shown phenotypes that display dysplastic AV valves, a
perimembranous ventricular septal defect (VSD), and a
secundum atrial septal defect (ASDII), (Donovan et al.,
2002; Gessler et al., 2002; Kokubo et al., 2004; Sakata et al.,
2002). Transthoracic echocardiographies revealed that AV
valve regurgitations, due to AV valve hypoplasia, were most
likely responsible for heart dysfunction in hesr2 homozy-
gous mutant mice (Kokubo et al., 2004). However, hesr2-
null mice do not show vascular defects, in contrast to
mutants of zebrafish gridlock, a homologue of hesr2, which
show with coarctation of the aorta (Zhong et al., 2000).
Morpholino knock-down experiments also indicate a role for
gridlock in arterial specification (Zhong et al., 2001).
Expression of hesr1 and hesr2 in both the cardiac and
vascular endothelium overlap at early stages of the develop-
ment (Fischer and Gessler, 2003; Iso et al., 2003) (our
unpublished data), suggesting possible functional redun-
dancy. We have now generated hesr1 homozygous mutant
mice, but they are viable and fertile, and show no obvious
phenotype (data not shown). We therefore hypothesized that
the phenotypic difference between the mouse and zebrafishhesr2 mutants might be due to differences in the compensa-
tory actions of other hesr gene family members.
Here, we report that mouse embryos lacking both hesr1
and hesr2 are embryonic lethal due to severe cardiovascular
malformations. Instead of forming paired left and right
ventricles, hesr1/2 double mutants have a single large
ventricle, indicating that ventricular septum formation is
blocked in the absence of both hesr1 and hesr2. In addition,
few cells underwent endocardial to mesenchymal transitions
in the developing AV cushions. Finally, arterial differ-
entiation is also defective in hesr1/2 double mutants. These
results highlight that essential roles of the hesr genes in the
control of critical early events in cardiovascular develop-
ment and suggest that they are essential downstream targets
of Notch signaling in the cardiovascular system.Material and methods
Knockout mice
To disrupt the hesr1 gene, a targeting vector was con-
structed with a complete deletion of the bHLH region from
exon1 through exon4, (see Supplementary Figure) using
hesr1 containing BAC clones derived from the RPCI-22
mouse BAC library (BACPAC resources, CA). The target-
ing vector was then electroporated into AB1 embryonic
stem (ES) cells. Colonies resistant to both neomycin
(positive selection) and FIAU (negative selection) were
screened by Southern blotting to identify correctly targeted
clones. The recombinants were subsequently injected into
C57B1/6 blastocysts to generate chimeras. Two independent
lines were finally obtained that transmitted the targeted
allele through the germ line. For genotyping, a PCR method
was developed to detect wild-type alleles, using a 3V
forward: CCCTCCCCTCCGTGCTTCTAACCTCAT/3V
reverse: CTCTCCCCACCCCACAAAGCAAAGCAG, pri-
mer set, and for the targeted allele a 3V reverse/Neo:
CGACCACCAAGGCGAAACATC primer set. The neo
cassette was removed by crossing the mice with CAG-Cre
mice and the genotype was determined using the 3Vreverse/
lacZ: CTCTGTGTCCTCATAAACCCTAACCTCCTT pri-
mer set. Mice containing a disrupted hesr2 gene have been
described in a separate manuscript (Kokubo et al., 2004).
Analysis of double mutants
All analyses were conducted on mice with a C57B1/6/
129Sv mix genetic background. Animals and embryos were
genotyped by PCR and in situ hybridizations were
performed using a whole mount in situ hybridization system
(M&S Instruments). Hematoxylin–eosin (HE) staining and
transmission electron microscopic observations were carried
out using standard methods (Miyagawa-Tomita et al., 1996).
We used the ApopTag Kit (Intergen, GA) to detect apoptotic
cells. Immunohistochemistry was performed using frozen
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Mingen), or anti-a-smooth muscle actin (SIGMA) primary
antibodies, and with alexa468-conjugated anti-rat or mouse
IgG (Molecular Probes) as a secondary antibody. The
corresponding signals were observed with an Olympus
fluorescence microscope system.Results
The hesr1//2/ shows embryonic lethal at around
10.5 dpc
To investigate the respective roles of hesr1 and hesr2
in cardiovascular development in the mouse, we inter-
crossed hesr1+//2+/ mice. At weaning, however, no
double homozygous mutant was found (Table 1), suggest-
ing that combined homozygosity at the hesr1 and hesr2
loci results in embryonic lethality. Although the number of
hesr1+//2/ mice obtained was significantly reduced,
some were found to be both viable and fertile, as was
previously observed for hesr2/ single knockout mice.
To define the stage at which the double mutant lethality
was occurring, timed pregnant matings were set up and
hesr1//2/ embryos were isolated at the expected
frequency until 10.5 dpc (Table 1). No hesr1//2/
embryos were observed beyond 11.5 dpc, indicating that
the double mutants die prior to this stage. At 10.5 dpc,
hesr1//2/ homozygous embryos were easily recog-
nized by their poorly formed telencephalic regions and
small first and second pharyngeal arches, as well as by
heart malformations and hemorrhaging (Figs. 1A and B).
These defects are therefore likely to be responsible for the
embryonic lethality observed in hesr1//2/ mice.
The hesr1//2/ embryos display anomalies in heart
development
Since previous studies of knockout mice have shown that
hesr2 has an important role in cardiac development,
particularly in the development of cardiomyocytes and in
AV valve formation, we first focused our analysis on heart
anomalies in hesr1//2/ embryos. At the gross level
hesr1//2/ hearts had only a single ventricle, whereas
hesr1+//2+/ hearts became to be divided into twoTable 1
Numbers of progeny obtained by intercrossing hesr1 and hesr2 mutants
Age (hesr1,2) +/+, +/+ +/+, +/ +/+, / +/, +/+ +/,
10 dpp (+/,
+/  +/, +/)
12 (9) 25 (18) 4 (9) 23 (18) 37 (3
10.5 dpc (+/,
/  /, +/)
19 (2
Genotypes of the progeny from the intercross between hesr1+//2+/ mice, or b
postpartum (dpp) or at day 10 postcoitum (dpc), respectively. hesr1//2/ mice
predicted numbers are parenthesized in the panel.ventricles (Figs. 1C and D). Histological examination also
revealed that the wall of the ventricle was thin and that the
trabecular zones and AV cushions had not properly formed
(Figs. 1C–F). At this stage, wild type, hesr1, hesr2 single
mutant embryos have undergone initial stage of chamber
formation, resulting in well-formed left and right atria and
ventricles (Figs. 2C and E). In contrast, hesr1//2/ mice
have a single open atria and ventricle, showing hypoplastic
myocardial trabeculae (Figs. 2D and F). During chamber
formation, the ventricular wall, accompanied by the
proliferation and accumulation of cardiomyocytes, gives
rise to two layers corresponding to the sub-epicardial
compact and sub-endocardial trabecular zones. Until 9.5
dpc, hesr1//2/ hearts with d-ventricular looping
showed a normal-sized ventricular chamber containing both
the compact and trabecular zones (Figs. 1G–J). These
observations suggested that in hesr1/2 double mutants, the
cardiomyocytes in the ventricle could successfully divide
into compact and trabecular zones, but that trabecular zone
cells are selectively lost at a later stage. We thus speculated
that apoptosis might be a contributing factor to this
phenotype. Indeed, many TUNEL-positive cells were found
in the trabecular zone but not in the compact zone at 10.0
dpc (Figs. 1K and L), although TUNNEL-positive cells
were not detected earlier at 9.5 dpc (data not shown). To
further characterize the nature of these cardiomyocyte
defects, the microstructure of the cardiomyocytes was
further analyzed via transmission electron microscopy.
Disorganized cardiomyocytes with fewer myofibrils, and
with swollen and irregular-shaped mitochondria, were
observed in hesr1//2/ mutants (Figs. 1M and N).
These observations suggest that poor trabecular formation
results in defects in cardiac chamber development.
Endocardial cushion development is essential for AV
valve formation. In the AV cushions, cardiac endothelial
cells undergo epithelial–mesenchymal transformation and
participate in the formation of valves and membranous
septa. Our analysis of hesr2 single mutants showed that AV
valve regurgitations due to hypoplasia of the valves were
most the likely cause of heart dysfunction in these mutant
mice, suggesting that hesr2 functions in either the formation
or maintenance of the AV valve. Our current studies favor
the former possibility. At 9.5 dpc, epithelial–mesenchymal
transformations in the AV canal occurred normally and on
schedule in the hesr+//2+/ embryo (Fig. 1O). In contrast,+/ +/, / /, +/+ /, +/ /, / ND Total
6) 10 (18) 17 (9) 16 (18) 0 (9) 12 155
2) 20 (22) 21 (22) 23 (22) 7 90
etween hesr1//2+/ and hesr1+//2/ mice were examined at day 10
were not detected at 10 dpp, but were evident at 10 dpc as expected. The
Fig. 1. Gross morphology and heart abnormalities in the hesr1//2/ embryo. (A, B) Comparison of a hesr1+//2+/ embryo (A) and a hesr1//2/ embryo
(B) at 10.5 dpc hesr1//2/ embryo shows small pharyngeal arch (arrow). (C, D) Frontal view of the hearts shown in A and B at higher magnification. The
hesr1+//2+/ heart is clearly divided into a primitive right ventricle (RV) and primitive left ventricle (LV) at the center of the chamber (arrowhead). In contrast, the
hesr1//2/ heart has a single chamber. Arrows indicate the center of the chamber. (E, F) HE-stained sections of 10.5 dpc embryonic hearts. The primitive four
chambers are well formed in the hesr1+//2+/ heart (E). AV cushion tissue is also well developed (arrowhead). A single primitive ventricle (PV) and right (RA)
and left (LA) atrium can be seen in the hesr1//2/ heart (F); the atrial septum is formed, but there is no interventricular septum. AV cushion tissue (arrowhead)
and the myocardial trabeculae of the ventricle are also not well formed. (G, H) HE-stained sections at 9.5 dpc. A primitive atrium (AT) and ventricle (PV) are
formed in both the hesr1+//2+/ (G) and the hesr1//2/ embryonic hearts (H), both hearts show normal d-ventricular looping. OT, outflow tract. (I, J)
Magnified view of the ventricular wall shown in G and H. The trabecular zone of the hesr1//2/ heart (indicated bar in panel J) appears thinner than that of the
hesr1+//2+/ heart (indicated bar in panel I). (K, L) Many apoptotic cells are detected by a TUNEL assay in the trabecular zone of the primitive
ventricle in the hesr1//2/ embryo (L) at 10.5 dpc. (M, N) TEM analysis, indicating that well-organized myofibrils (Mf) and mitochondria (Mt) are
evident at 10.5 dpc in the ventricle of the hesr1+//2+/ embryo (M). In contrast, disorganized myofibrils and swollen mitochondria (arrowhead) are
observed in the hesr1//2/ embryo (N). Nu, nucleus. (O, P) Magnified HE section at the atrioventricular cushion of G and H. Transformed
mesenchymal cells (arrows) from the endocardium are observed in the hesr1+//2+/ embryo (O), whereas few are seen in the hesr1//2/ embryo (P).
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lial cell transformation although the AV cushion was
enriched in extracellular matrix (Fig. 1P). These observa-
tions suggest that both hesr1 and 2 play redundant roles in
epithelial–mesenchymal transformation during AV valve
formation.
Left–right ventricle identity is unaffected in the
hesr1//2/ heart
In the hesr1//2/ mutant hearts, only a single
ventricle was formed at the gross level. This lack of left–right ventricular formation could be due to either an inability
to specify either the left or right ventricles. Alternatively, the
ventricular defects could be due to a failure to undergo
morphogenetic changes required for ventricular septation.
To test these possibilities, we examined the expression of
marker genes for cardiac development and for ventricular
right–left polarity. Expression of nkx2.5, the earliest gene
expressed in the cardiac lineage (Harvey, 1996; Lyons et al.,
1995), was normal in hesr1//2/ hearts (Figs. 2A and
B), indicating that general cardiac cell type specification
was unaltered. Additionally, the expression of ehand, which
is normally only detected in the left ventricle at 10.5 dpc
Fig. 2. In situ hybridization analyses using ventricular and atrial markers in 10.5 dpc hearts. (A, B) nkx2.5 is expressed in both the right (RV) and left (LV)
ventricles of the hesr1+//2+/ (A) and hesr1//2/ embryos (B). A frontal view is shown. (C, D) In the hesr1+//2+/ heart (C), ehand expression is
normally restricted to the left ventricle but in the hesr1//2/ heart (D), is restricted to the left half of the single ventricle (arrows indicate the edge of the
zone of expression). (E, F) dhand expression in the hesr1//2/ heart (Fa) is reduced over the whole ventricle compared to the hesr1+//2+/ heart (Ea).
Expression patterns of dhand in the whole embryos are shown in Eb (hesr1+//2+/) and Fb (hesr1//2/). Signal is normally restricted in the posterior
region of limb (arrowhead in Ea), but in the hesr1//2/ limb, signal is expanded to the anterior region (indicated bar in Fb). (G, H), Irx4 is expressed in
the ventricles of the hesr1+//2+/ (G) and the hesr1//2/ (H) embryonic hearts (arrows indicate the border of the different expression levels). (I, J)
Expression levels of the myosin light chain atrium (MLCa) gene are shown in frontal (a) and left lateral (b) views. The MLCa gene is normally expressed in
both embryonic atria and ventricles and, the pattern of expression is normal in the hesr1//2/ embryos. (K, L) Expression of the myosin light chain
ventricle (MLCv) gene is shown in frontal (a) and left lateral (b) views. MLCv gene expression is restricted in the ventricles of both the hesr1+//2+/ and the
hesr1//2/ embryos.
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the left side of the ventricle in the hesr1/2 double knockout
mice (Figs. 2C and D), indicating the left side of the
ventricle was correctly specified. Transcription of dhand
normally occurs in both ventricles and is then enhanced in
the right ventricle (Srivastava et al., 1995; Yamagishi et al.,
2000), but was significantly reduced in the hesr1//2/
mice (Figs. 2Ea and Fa). In addition to the heart, dhand
expression is reduced even other regions including the limb
bud, in which the normal posterior restricted domain of
dhand expression is not observed in the hesr1//2/
mutant embryos. These results may indicate that Notch sig-
naling and/or hesr1/2 function is involved in the AP
specification of limb bud (Figs. 2Fb and Eb). In the
hesr1//2/ heart, Irx4, a ventricle-specific homeobox
gene, was normally expressed (Figs. 2G and H), and ex-pression of the atrial and ventricular muscle-specific differ-
ential markers, MLCa and MLCv (Kubalak et al., 1994),
was also normal, indicating that atrial and ventricular
specification and terminal differentiation were unaffected
(Figs. 2I–L). We conclude therefore that hesr1 and hesr2 are
essential for myocardial trabecular proliferation of the
ventricle rather than for the establishment of the right–left
polarity of the cardiac chamber.
The hesr1//2/ embryos display vascular defects
The hesr2 single mutants do not show vascular defects
(Donovan et al., 2002; Gessler et al., 2002; Kokubo et al.,
2004; Sakata et al., 2002). On the other hand, mutation of
zebrafish gridlock, a homologue of hesr2, is associated with
coarctation of the aorta (Zhong et al., 2000). Expression of
H. Kokubo et al. / Developmental Biology 278 (2005) 301–309306hesr1 and hesr2 in the vascular endothelium is found to
overlap at an early stage of development (Fischer and
Gessler, 2003; Iso et al., 2003) (our unpublished data). We
thus hypothesized that the phenotypic difference between
the mouse and zebrafish mutants was due to differences in
the compensatory actions of the hesr gene family members.
Defects in blood vessel development were also evident in
hesr1//2/ embryos. In yolk sacs, large blood vessels
were not formed in the double mutants (Fig. 3B). In
contrast, in wild-type embryos and in single knockout hesr1
or hesr2 mutants at E10.5, remodeling of vessels occurs to
form larger vessels and blood circulation commences in the
yolk sac (Fig. 3A). In the hesr1/2 double mutants, small
blood vessels in the yolk sac itself were present (Fig. 3D),
suggesting that hesr1 and hesr2 are redundantly required for
the remodeling of vessels in the yolk sac. Additionally, in
the hesr1/2 double mutant embryos, as seen for hesr1 or
hesr2 single mutants, large vessels, including cardiac vein
and dorsal aorta, were normally positioned following ink
injection and HE staining analysis (Figs. 3E–H). However,
ink injection into both the vitelline artery and veins couldFig. 3. Vascular defects in the hesr1//2/ mutant. (A, B) Yolk sacs of hesr1+/
vessels is evident in the freshly dissected hesr1//2/ yolk sac. (C, D) Whole-m
are seen in the hesr1+//2+/ yolk sac whereas only small capillaries are evident in
visualized by ink-injection of the 10.0 dpc embryos showing that rostral is up and
in parallel along the sides of the body, and also the first, second and third aortic arc
vein (arrows), dorsal aorta, and aortic arches are formed in the hesr1//2/ embr
vascular branches (red arrowheads). Although the right sinus horn appears normal,
hesr1//2/ embryo shows a smaller size compared to that of the hesr1+//2+/
level (data not shown). (G, H) HE-stained cross-sections in the head region. The
and hesr1//2/ embryos. The dorsal aortas are magnified in the right upper pan
in hesr1+//2+/ embryos. (I–N) Antibody staining of adjacent sections of the hea
(K, N). Expression levels of ephrin-B2 (M) and a-smooth muscle actin (N) are
embryo (J and K), whereas PECAM expression appears unaffected (compare I wnot directly reach the cardinal vein in the double mutants but
instead, the ink filled several small vessels connecting the
dorsal aorta and cardinal vein (red arrow in Fig. 3F).
Histologically, the cell layers surrounding the arteries
were thinner in the double mutants than in the correspond-
ing double heterozygotes, which prompted us to speculate
that hesr1/2 double mutants have arterial specification
defects. To test this possibility, we examined the expression
of Ephrin-B2 and smooth muscle actin (SMA), both of
which are expressed in the mesenchyme surrounding the
endothelium of developing arteries, but not in developing
veins at this stage of embryogenesis and thus can distinguish
arteries and veins. In hesr1/2 double mutants, we observed a
large vessel in the position of the dorsal aorta that is
prominently stained by PECAM-1 (Figs. 3I, L). Unlike
wild-type or single mutant embryos, hesr1/2 double
homozygous mutants do not express either SMA or
Ephrin-B2, indicating that arterial formation requires either
hesr1 or hesr2 activity. Hence, the roles of the hesr gene
family in arterial-venous differentiation are conserved
between zebrafish and mouse./2+/ (A) and hesr1//2/ embryos (B) at 10.5 dpc. The absence of major
ount immunohistochemical staining for PECAM-1. Large and small vessels
the hesr1//2/ yolk sac. (E, F) Major vasculature in the trunk region is
dorsal is left. The anterior cardinal vein (CV) and dorsal aorta (DA) running
hes (I, II, III) can be seen in the wild-type embryo (E). The anterior cardinal
yo, but the anterior cardinal vein is connected to the dorsal aorta by multiple
the size of the common cardinal vein is reduced. A pair of dorsal aorta in the
embryo and fails to be assembled in the common dorsal aorta at the caudal
anterior cardinal vein and dorsal aorta are present in both the hesr1+//2+/
els. The cell layer surrounding the artery in the double mutant is thinner than
d region for PECAM-1 (I, L), ephrin-B2 (J, M), and a-smooth muscle actin
decreased in the hesr1//2/ embryo compared with the hesr1+//2+/
ith L). The dorsal aorta is indicated by arrowheads.
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Our results indicate that the Notch signaling pathway, via
the hesr1 and hesr2 effectors, plays an important role in
cardiac morphogenesis and in angiogenesis. hesr1//2/
mice have defects in myocardial trabeculation and cardiac
endothelial cell transformation, as well as in angiogenesis.
Although there are arguments as to whether the cardiac
defects or the vascular defects are primary or secondary to
each other, both defects could occur independently. In
support of a primary role for hesr1 and hesr2 in vascular
development, small blood vessels were present in the yolk
sac, and blood vessels for great arteries or veins themselves
are formed in the hesr1//2/ embryos, and blood
circulation was detected up to at least 10.0 dpc. The major
defect we found in the vasculature of the hesr1//2/
embryos was in the specification of artery vs. vein, which is
detected as early as 9.5 dpc in wild-type or single-mutant
embryos. The early development of the cardiac and vascular
systems occurs independently until circulation starts about
at 9.0 dpc. Thus, we think that it is unlikely that the defect
in arterial-venous specification that we observe in the
hesr1//2/ mutants is secondary to cardiac defects.
With respect to whether the cardiac defects we observe in
the hesr1//2/ mutants are direct or indirect, it should
be noted that since endocardial transformation and myo-
cardial differentiation occur after cardiac contractions
initiate, it is therefore possible that these processes may
be affected indirectly by defects in blood circulation.
However, we have observed cardiac anomalies in hesr2-
single knockout mice without any obvious defects in the
vasculature. Collectively favors the idea that the defects we
observed in the heart and the arteries of the hesr1//2/
mutants are primary defects in each system. However, we
cannot exclude the possibility that some defects are
secondary and we will require tissue-specific deletion of
hesr genes in cardiac and/or vascular tissues to address the
possibility that the phenotypes we observe are indirect.
Synergistic functions of hesr1 and hesr2 in heart
development
The hesr1//2/ embryonic hearts had little EMT in
the AV cushion tissue, whereas the hesr1 single mutant
displayed no heart anomalies (our unpublished data),
although some hesr2 single mutants showed dysfunction
of the AV valves (Kokubo et al., 2004). This indicates that
hesr1 and hesr2 are necessary for EMT, but also they can
compensate for each other in this process. TGFh2, which is
restricted to the AV canal myocardium, was shown to be
downregulated in the RBPJk mutants (Timmerman et al.,
2004). In hesr1//2/ embryonic hearts, expression of
TGFh2 is reduced (Supplemental Fig. S2), suggesting that
endocardial Notch activity somehow affects myocardial
TGFh2 expression, likely through hesr1 and hesr2.
However, hesr2 and/or hesr1 are unlikely to be sufficientto induce EMT in the AV cushion tissue as this trans-
formation fails to occur in RBPJk mutants, even though
hesr2 expression is maintained in this mutant (Timmerman
et al., 2004). We speculate that other gene(s) may be
activated by Notch1/RBPJk that, together with hesr1 and
hesr2, are necessary for the induction of EMT. In this
context, the zinc finger transcription factor snail is a likely
candidate since the expression is known to be down-
regulated in RBPJk-null embryonic heart and it can repress
E-cadherin expression to induce EMT in epithelial tumor
cells (Timmerman et al., 2004). In addition, BMP2 is also
know to be involved in EMT (Keyes et al., 2003; Sugi et al.,
2004) and cross talk with Notch and BMP2 signaling has
been suggested in this context (Takizawa et al., 2003).
Recent studies have shown that hesr1 expression could be
synergistically activated by BMP and Notch signaling (Itoh
et al., 2004). Expression of bmp2 is normally detected in the
atrium through the AV canal in both hesr1+//2+/ and
hesr1//2/ embryonic hearts (Supplemental Fig. S2),
however, this BMP signal may not be processed properly in
the absence of hesr1 and hesr2, which might result in the
suppression of EMT. Further studies will be required to
elucidate the molecular mechanism underlining EMT with
regard to Notch and BMP signaling and hesr1/2 function.
The hesr1//2/ hearts displayed a hypomorphic
ventricular trabecular zone. Although a mild cardiomyocyte
defect was seen in the hesr2/ single mutant, the formation
of the trabecular zone itself was not affected in either of the
hesr1 or hesr2 single knockout mutants. It has been
previously suggested that the inner cardiac endothelium
regulates maturation of the outer myocardium and that this
is required for trabecular formation (Brutsaert et al., 1998).
Our studies demonstrate that expression of hesr1 in
endocardial cells and of hesr2 in myocardial cells are
required for trabecular formation. In either Notch1 or
RBPJk mutants, a myocardial defect was not reported,
although Notch2 is expressed in the myocardial cells and its
hypomorphic mutant has been shown to exhibit a thinning
of the myocardial wall (McCright et al., 2002). The defect in
ventricular formation in the hesr1//2/ embryonic heart
showed a more severe phenotype than this, suggesting that
there may be a similar functional role between Notch1
expressed in endocardial cells and Notch2 in myocardial
cells.
hesr1 has been reported to be a downstream target of
Notch1 signaling through the RBPJk transcription factor in
vitro (Iso et al., 2002). Since Notch1, RBPJk and hesr1 are
co-expressed in the endocardium and hesr1 expression was
absent in the RBPJk mutant (Timmerman et al., 2004), this
suggested that hesr1 should be activated by Notch1 through
RBPJk in vivo. The regulation of hesr2, however, appears
not to be solely dependent on Notch1 and RBPJk, and since
its expression is not affected in the RBPJk mutant, its
expression in these tissues is must be controlled via another
mechanism. Of particular interest in this regard is the
expression of Notch2 in the myocardium (McCright et al.,
H. Kokubo et al. / Developmental Biology 278 (2005) 301–3093082002), which is similar to that of hesr2, suggesting that
Notch2 might play a role in hesr2 regulation.
Of further interest is the control mechanism by which
hesr proteins modulate cardiovascular development. Infor-
mation of downstream targets of hesr proteins still remains
uncertain. From our studies, one possible downstream
target of hesrs is dhand, since the expression of dhand
was reduced in the hesr1//2/ embryonic heart. Mice
lacking dhand have a single ventricle that exhibit hypo-
trabeculation and aortic arch defects and die by 11.0 dpc
due to the heart failure (Srivastava et al., 1995; Yamagishi
et al., 2000). Therefore, simple explanation for phenotype
of the hesr1//2/ heart might be due reduced dhand
expression. In this context, it is interesting that the
expression level and/or pattern of dhand is altered even
in other regions such as pharyngeal arch, limb bud and
lateral mesoderm. Since hesr proteins have been shown to
function in vitro as transcriptional repressors, regulation of
dhand expression by hesr1 and/or hesr2 may be indirect.
Further analysis will be necessary to identify the mecha-
nism of how dhand is regulated through either Notch
signaling or hesrs proteins.
The synergistic functions of hesr1 and hesr2 in vascular
development
The hesr gene family is composed of three members and
their expression overlaps in the vasculature, especially in the
aorta. In this report, we demonstrate a requirement for hesr1
and hesr2 in vascular and cardiac development, raising the
question of whether hesr3 is unable to compensate for the
combined loss of hesr1 and hesr2. One possibility is that
hesr3 is unable to substitute for hesr1 and hesr2 function.
Alternatively, the expression of hesr3 may be altered in
hesr1//2/ mutants. To distinguish between these
possibilities, we examined whether hesr3 is expressed in
the hesr1//2/ embryos by in situ hybridization analy-
sis. We found that the expression of hesr3 is significantly
reduced in the hesr1//2/ embryos (Supplemental Fig.
S3). Although the mechanism of hesr3 downregulation
mediated by hesr1 and/or hesr2 remains uncertain, this
downregulation of hesr3 explain why hesr3 does not
compensate for hesr1 and hesr2 in the hesr1//2/
mutant.
Notch signaling regulates many aspects of cell-fate
decisions and of particular relevance to this report plays a
critical role in vascular development, especially in remodel-
ing and in arterial-venous specification (Krebs et al., 2000),
may act together with ephrinB2 and EphB4 in arterial-
venous specification (Lawson et al., 2001; Shawber et al.,
2003). Eph receptor tyrosine kinases and their transmem-
brane ephrinB ligands are expressed in the developing
circulatory system, and mice lacking either ephrinB2 or
EphB4 have similar phenotypes to hesr1//2/ mice,
including defects in angiogenic remodeling and poor
myocardial trabeculation. Additionally, several studies havenow suggested that ephrin-Eph signaling is required for
angiogenesis (Adams et al., 1999; Gerety and Anderson,
2002; Gerety et al., 1999; Wang et al., 1998). Reduced
expression of ephrinB2 was also seen in hesr1//2/
mice. These findings suggest that ephrin-Eph signaling,
particularly ephrinB2 expression, could be regulated, either
directly or indirectly, by Notch signaling via the hesr genes
during cardiovascular development. Further analysis will
be necessary to identify the signaling pathways involved in
the endothelial cells of the developing cardiovascular
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